ADVFN ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Eden Research Secures Syngenta Partnership for Evelta Fungicide Rollout

Market News
18 December 2025 8:22AM

Eden Research plc (LSE:EDEN) has entered into an exclusive distribution agreement with Syngenta Crop Protection AG for its fungicide product Evelta™, covering the professional ornamental crop market across several European Union countries and the UK. The deal represents Eden’s first commercial partnership with a major global crop protection group and marks a significant step in broadening the company’s commercial footprint.

Under the agreement, Syngenta will manage the distribution of Evelta™, supporting Eden’s strategy to accelerate market penetration while maintaining a focus on sustainable crop protection solutions. Management said the partnership is expected to strengthen execution capabilities, extend reach to professional growers, and enhance long-term value creation for stakeholders.

From a market perspective, Eden continues to face financial headwinds alongside cautious technical signals. However, recent corporate developments, including regulatory approvals for its products and instances of insider share purchases, are viewed as constructive indicators that could support future growth and improved investor sentiment.

More about Eden Research

Eden Research plc develops sustainable biopesticide and biocontrol technologies for the global agricultural sector. The company focuses on environmentally responsible fungicides and works with international partners to expand market access, helping growers adopt more sustainable and effective crop protection practices.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.
Some portions of this content may have been generated or assisted by artificial intelligence (AI) tools and been reviewed for accuracy and quality by our editorial team.